Edition:
India

Hologic Inc (HOLX.OQ)

HOLX.OQ on NASDAQ Stock Exchange Global Select Market

43.46USD
19 Jan 2018
Change (% chg)

$-0.39 (-0.89%)
Prev Close
$43.85
Open
$43.20
Day's High
$43.57
Day's Low
$42.56
Volume
1,213,217
Avg. Vol
906,842
52-wk High
$46.80
52-wk Low
$35.78

Chart for

About

Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women's health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays,... (more)

Overall

Beta: 0.94
Market Cap(Mil.): $10,571.04
Shares Outstanding(Mil.): 280.47
Dividend: --
Yield (%): --

Financials

BRIEF-Third Respiratory Assay now FDA cleared on Hologic's new Panther Fusion system

* THIRD RESPIRATORY ASSAY NOW FDA CLEARED ON HOLOGIC'S NEW PANTHER FUSION® SYSTEM

06 Dec 2017

BRIEF-HOLOGIC RECEIVES FDA 510(K) CLEARANCE OF QUANTRA 2.2 BREAST DENSITY ASSESSMENT SOFTWARE

* HOLOGIC RECEIVES FDA 510(K) CLEARANCE OF QUANTRA 2.2 BREAST DENSITY ASSESSMENT SOFTWARE

24 Nov 2017

BRIEF-Hologic announces upcoming put option

* Hologic announces upcoming put option and notice of redemption of 2.00% convertible senior notes due 2043 Source text for Eikon: Further company coverage:

15 Nov 2017

BRIEF-Hologic announces Q4 GAAP earnings per share $0.29

* Hologic announces financial results for fourth quarter of fiscal 2017

09 Nov 2017

BRIEF-Hologic - ‍received 510(k) clearance from FDA for Panther Fusion Paraflu assay​

* Hologic Inc - ‍received 510(k) clearance from FDA for Panther Fusion Paraflu assay​ Source text for Eikon: Further company coverage:

26 Oct 2017

Siemens mandates three banks for IPO of Healthineers unit: sources

FRANKFURT Germany's Siemens AG has mandated Goldman Sachs, Deutsche Bank and JP Morgan as lead organisers of an initial public offering (IPO) of its Healthineers unit, sources familiar with the matter said.

24 Oct 2017

BRIEF-Hologic prices offering of $350 mln 4.375 pct senior notes due 2025

* Hologic announces pricing of offering of $350 million aggregate principal amount of 4.375% senior notes due 2025

05 Oct 2017

BRIEF-Hologic announces offering of $350 mln of senior notes due 2025

* Hologic announces offering of $350 million of senior notes due 2025

04 Oct 2017

BRIEF-Hologic enters into amended and restated five-year secured credit agreement

* Hologic enters into amended and restated five-year secured credit agreement

04 Oct 2017

BRIEF-Hologic receives FDA 510(k) clearance to market SculpSure

* Hologic receives FDA 510(k) clearance to market SculpSure for non-invasive body contouring (lipolysis) of the submental area (under the chin)

27 Sep 2017

Competitors

Earnings vs. Estimates